The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma—including the analysis of clinicopathological factors influencing relative dose intensity

Recently, it has been reported that the relative dose intensity (RDI) of adjuvant chemotherapy (AC) influences survival in various cancers, but there are very few reports about RDI in pancreatic ductal adenocarcinoma (PDAC). The optimal timing for initiation of AC for PDAC also remains unknown. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabusaki, Norimitsu, Fujii, Tsutomu, Yamada, Suguru, Murotani, Kenta, Sugimoto, Hiroyuki, Kanda, Mitsuro, Nakayama, Goro, Koike, Masahiko, Fujiwara, Michitaka, Kodera, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265784/
https://www.ncbi.nlm.nih.gov/pubmed/27442667
http://dx.doi.org/10.1097/MD.0000000000004282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265784/
https://www.ncbi.nlm.nih.gov/pubmed/27442667
http://dx.doi.org/10.1097/MD.0000000000004282

Ejemplares similares